Evogene Ltd (NASDAQ:EVGN) Short Interest Up 62.3% in July

Share on StockTwits

Evogene Ltd (NASDAQ:EVGN) saw a significant increase in short interest in July. As of July 15th, there was short interest totalling 57,300 shares, an increase of 62.3% from the June 30th total of 35,300 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 116,500 shares, the days-to-cover ratio is presently 0.5 days.

An institutional investor recently raised its position in Evogene stock. Jane Street Group LLC boosted its position in Evogene Ltd (NASDAQ:EVGN) by 153.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 32,000 shares of the biotechnology company’s stock after acquiring an additional 19,382 shares during the period. Jane Street Group LLC owned 0.12% of Evogene worth $38,000 at the end of the most recent quarter. 26.10% of the stock is owned by hedge funds and other institutional investors.

Evogene stock opened at $1.04 on Friday. The business’s 50-day simple moving average is $1.05 and its 200 day simple moving average is $1.19. Evogene has a 12-month low of $0.75 and a 12-month high of $1.83. The company has a current ratio of 9.55, a quick ratio of 9.55 and a debt-to-equity ratio of 0.03.

Evogene (NASDAQ:EVGN) last posted its quarterly earnings results on Tuesday, May 26th. The biotechnology company reported ($0.24) earnings per share (EPS) for the quarter. The firm had revenue of $0.08 million during the quarter. Evogene had a negative net margin of 4,298.13% and a negative return on equity of 36.82%.

Evogene Company Profile

Evogene Ltd., a biotechnology company, engages in developing various products for various life science markets through the use of computational predictive biology platform in the United States, Germany, and internationally. It discovers and develops products in various areas, including ag-chemicals, ag-biologicals, seed traits, integrated castor oil ag-solutions, and human microbiome-based therapeutics.

Read More: Backdoor Roth IRA Conversion and Strategy

Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Invitation Homes Inc  Shares Acquired by ProShare Advisors LLC
Invitation Homes Inc Shares Acquired by ProShare Advisors LLC
Coastal Capital Group Inc. Sells 19 Shares of Amazon.com, Inc.
Coastal Capital Group Inc. Sells 19 Shares of Amazon.com, Inc.
Amazon.com, Inc.  Stock Position Lifted by K.J. Harrison & Partners Inc
Amazon.com, Inc. Stock Position Lifted by K.J. Harrison & Partners Inc
Quantitative Systematic Strategies LLC Purchases New Stake in BJs Wholesale Club Holdings Inc
Quantitative Systematic Strategies LLC Purchases New Stake in BJs Wholesale Club Holdings Inc
Quantitative Systematic Strategies LLC Buys New Position in Nokia Oyj
Quantitative Systematic Strategies LLC Buys New Position in Nokia Oyj
Probity Advisors Inc. Sells 4 Shares of Amazon.com, Inc.
Probity Advisors Inc. Sells 4 Shares of Amazon.com, Inc.


© 2006-2020 Ticker Report